Drug comparisons
Pioglitazone vs Glyburide
Pioglitazone vs Glyburide: Actos (TZD) reduces insulin resistance (HF black box) vs Glynase (SU) increases insulin (hypo risk) in type 2 diabetes.
No comparison dimensions are available for this page.
Clinical context
This comparison is typically triggered when selecting an oral antidiabetic agent for type 2 diabetes patients, balancing insulin resistance treatment against insulin secretion stimulation and associated risks like heart failure or hypoglycemia.
Bottom line
The better drug depends on individual factors such as cardiovascular status, hypoglycemia risk, and cost, with neither being superior overall.
All medication comparisons